By capping Medicare out-of-pocket expenses at $2000 a year, the Inflation Reduction Act will allow more patients with heart failure to access lifesaving treatments, cardiologists say.
The trial blasts the common view that torsemide offers advantages over furosemide in heart failure, but its offbeat design raises caution about interpretation.
Elevated systolic pressures may help weaken the impact of low LVEF on short- and long-term CV events in patients with acute myocardial infarction, a cohort study suggests.
A small molecule produced by the gut microbiome from dietary protein may contribute to development of heart failure and is worth exploring as a possible therapeutic target, researchers say.